GLP-1 RAs are an established class of glucose-lowering medication that significantly decrease fasting and post-prandial levels of blood glucose, glycated hemoglobin, and body weight in patients with type 2 diabetes mellitus (T2DM) [1]. This evidence concerns the gene GLP1R and diabetes mellitus.